A long way from actual clinical applicability, but interesting anyway …

There was an intriguing paper in the November 2013 issue of the journal Prostate suggesting that intermittent dosing with testosterone in between doses of androgen deprivation therapies may actually help men in the early stages of castration resistance to respond better to treatment over time. … READ MORE …

OMG … The finger length/prostate cancer risk hypothesis is back again

In July 2010 we commented on an article in The Daily Mail that was based on data from a team of Korean researchers who’d been busily measuring the lengths of the second and fourth fingers of the right hands of men presenting at their urology clinic. They were convinced that there was a correlation between relative finger length and risk for prostate cancer. … READ MORE …

Out on the frontiers of research on the genetics of cancer

For those who like to know what is happening out on the farther reaches of cancer research, there is an interesting article by George Johnson in today’s New York Times. … READ MORE …

Re-thinking the research model for future prostate cancer therapies

In February this year Efstathiou and Logothetis published an article in Clinical Cancer Research stating that the traditional model of cancer drug development — seeking agents that had some activity in very later stages of the cancer and then “working backwards” to explore the effects of these agents earlier in the disease — had been ineffective in prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,133 other followers